In fact, a different mechanism mainly concerning the perforin-dependent pathway [20] is responsible for GVL; thus, G-CSF mobilized grafts are able to retain their GVL effects while benefiting from decreased GVHD severity. This evidence concerns the gene PRF1 and graft versus host disease.